BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18376526)

  • 1. [The pivotal role of the pathologist in transplantation].
    Rotman S; Fontana M; Seydoux C; Venetz JP; Aubert JD; Pascual M
    Rev Med Suisse; 2008 Feb; 4(145):480-3. PubMed ID: 18376526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should we be doing routine biopsy after heart transplantation in a new era of anti-rejection?
    Patel JK; Kobashigawa JA
    Curr Opin Cardiol; 2006 Mar; 21(2):127-31. PubMed ID: 16470149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractory humoral cardiac allograft rejection successfully treated with a single dose of rituximab.
    Baran DA; Lubitz S; Alvi S; Fallon JT; Kaplan S; Galin I; Correa R; Courtney MC; Chan M; Spielvogel D; Lansman SL; Gass AL
    Transplant Proc; 2004 Dec; 36(10):3164-6. PubMed ID: 15686719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of acute humoral rejection in a heart transplant patient.
    Malafa M; Mancini MC; Myles JL; Gohara A; Dickinson JM; Walsh TE
    J Heart Lung Transplant; 1992; 11(3 Pt 1):486-91. PubMed ID: 1610857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late onset antibody-mediated rejection and endothelial localization of vascular endothelial growth factor are associated with development of cardiac allograft vasculopathy.
    Bayliss J; Bailey M; Leet A; Stein AN; Thomson NM; McLean CA
    Transplantation; 2008 Oct; 86(7):991-7. PubMed ID: 18852667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute pancreatitis complicating OKT3 administration for resistant cardiac rejection.
    Scheinin S; Radovancevic B; Frazier OH
    Transplant Proc; 1993 Jun; 25(3):2368-9. PubMed ID: 8516933
    [No Abstract]   [Full Text] [Related]  

  • 7. Optimal timing for surveillance endomyocardial biopsies in heart transplant patients receiving antithymocyte globulin induction.
    Cantarovich M; de Gruchy S; Forbes C; Marpole D; Elstein E; Magnan C; de Varennes B
    Transplant Proc; 1999; 31(1-2):79. PubMed ID: 10083015
    [No Abstract]   [Full Text] [Related]  

  • 8. Evolution of chronic antibody mediated-rejection: a case report.
    Cornell LD; Wong W; Saidman S; Collins AB; Colvin RB
    Clin Transpl; 2006; ():463-7. PubMed ID: 18365404
    [No Abstract]   [Full Text] [Related]  

  • 9. [Heart transplantation. Indications, results and perspectives].
    Wahlers T; Pethig K; Fieguth HG; Demertzis S; Hausen B; Mügge A; Wolpers K; Heublein B; Borst HG
    Internist (Berl); 1996 Mar; 37(3):283-8. PubMed ID: 8919945
    [No Abstract]   [Full Text] [Related]  

  • 10. Prediction of subclinical renal allograft rejection by vascular endothelial growth factor in serum and urine.
    Peng W; Chen J; Jiang Y; Shou Z; Chen Y; Wang H
    J Nephrol; 2008; 21(4):535-42. PubMed ID: 18651543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening biopsies in kidney transplantation: from subclinical acute rejection to chronic allograft lesions].
    Snanoudj R; Martinez F; Sberro Soussan R; Thervet E; Legendre C
    Nephrol Ther; 2008 Oct; 4 Suppl 3():S192-9. PubMed ID: 19000886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-mediated rejection without acute graft dysfunction in adult ABO-compatible heart transplantation: a case of accommodation.
    Angelini A; Castellani C; Poli F; Benazzi E; Torregrossa G; Tona F; Gambino A; Caforio AP; Feltrin G; Toscano G; Valente M; Thiene G; Gerosa G
    J Heart Lung Transplant; 2008 Dec; 27(12):1357-60. PubMed ID: 19059119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection.
    Stewart S; Winters GL; Fishbein MC; Tazelaar HD; Kobashigawa J; Abrams J; Andersen CB; Angelini A; Berry GJ; Burke MM; Demetris AJ; Hammond E; Itescu S; Marboe CC; McManus B; Reed EF; Reinsmoen NL; Rodriguez ER; Rose AG; Rose M; Suciu-Focia N; Zeevi A; Billingham ME
    J Heart Lung Transplant; 2005 Nov; 24(11):1710-20. PubMed ID: 16297770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-dependent changes in B-type natriuretic peptide after heart transplantation: correlation with allograft rejection and function.
    Bader FM; Rogers RK; Kfoury AG; Gilbert EM; Horne BD; Stehlik J; Renlund DG
    Congest Heart Fail; 2009; 15(2):63-7. PubMed ID: 19379451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C4d-the witness of humoral rejection.
    de Gouveia RH; Vitorino E; Ramos S; Rebocho MJ; Queirós E Melo J; Martins AP; Moura ML
    Transplant Proc; 2009 Apr; 41(3):866-7. PubMed ID: 19376374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heart transplantation: life-long biopsies for prevention of rejection?].
    Stallmach T; Gaspert A; Ersch J; Oechslin E
    Schweiz Med Wochenschr; 2000 Jun; 130(25):957-62. PubMed ID: 10909723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocytolysis in heart transplant patients.
    Sgrosso JL; Parisi C; Ahualli L; Romeo L; Esteban W; Cammarata C
    Transplant Proc; 1996 Dec; 28(6):3325-7. PubMed ID: 8962291
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical and pathological analysis of acute rejection following orthotopic liver transplantation.
    Ma Y; Wang GD; He XS; Li JL; Zhu XF; Hu RD
    Chin Med J (Engl); 2009 Jun; 122(12):1400-3. PubMed ID: 19567160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial monitoring of humoral antibody-mediated rejection of cardiac allografts by C4d staining of interstitial capillaries.
    Suggs J; Goodin J; Cruse JM; Lewis RE; Allen B; Bigler S; Moore C; Thompson R; McIntire H
    Exp Mol Pathol; 2009 Feb; 86(1):41-5. PubMed ID: 19111538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of the pathologist in the clinical management of the heart transplant patient].
    Baroldi G
    Cardiologia; 1995 Oct; 40(10):713-6. PubMed ID: 8819731
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.